| Nandrolone Phenpropionate |
Hormones and hormonal mechanisms
|
Breast cancer
|
Yes
|
| Type 1 5-alpha Reductase Inhibitor |
Chemotherapy
|
Prostate cancer
|
Yes
|
| TriGem |
Biologic therapy (BRM, immunotherapy)
|
Lung,
skin cancer
|
Yes
|
| Emofolin |
Chemotherapy
|
|
Yes
|
| Fluprednisolone Valerate |
Hormones and hormonal mechanisms
|
|
Yes
|
| Estradiol Cypionate |
Hormones and hormonal mechanisms
|
|
Yes
|
| Xofigo |
Radiation
|
Metastatic prostate cancer
|
Yes
|
| Palbociclib |
Chemotherapy
|
Breast
|
Yes
|
| Ibrutinib |
Chemotherapy
|
B-cell malignancies,
CLL,
Mantle cell lymphoma,
Multiple myeloma,
NHL,
Waldentrom macroglobulinemia (WM),
diffuese B-cell lymphoma,
SLL
|
Yes
|
| Estrogens, Conjugated |
Hormones and hormonal mechanisms
|
|
Yes
|
| Mitomalcin |
Chemotherapy
|
|
Yes
|
| ENMD 0995 |
Chemotherapy
|
Lymphoma,
Multiple myeloma
|
Yes
|
| Estradiol Mustard |
Hormones and hormonal mechanisms
|
|
Yes
|
| Enhanzyn |
Biologic therapy (BRM, immunotherapy)
|
Breast cancer
|
Yes
|
| Mitocarcin |
Chemotherapy
|
|
Yes
|
| Uracil Mustard |
Chemotherapy
|
|
Yes
|
| PD 0332991 |
Chemotherapy
|
ER positive/ HER2-negative breast cancer
|
Yes
|
| Urethane |
Chemotherapy
|
|
Yes
|
| 109881 |
Chemotherapy
|
Brain cancer
|
Yes
|
| UBITh |
Ancillary Agent,
Biologic therapy (BRM, immunotherapy)
|
Prostate cancer
|
Yes
|
| Ethidium chloride |
Chemotherapy
|
|
Yes
|
| MGS rCEA (recombinant carcinoembryonic antigen) |
Biologic therapy (BRM, immunotherapy)
|
Colorectal cancer
|
Yes
|
| Vismodegib |
Chemotherapy
|
Basal cell carcinoma, skin
|
Yes
|
| Fluoxymesterone |
Hormones and hormonal mechanisms
|
Breast cancer
|
Yes
|
| Methylprednisolone Acetate |
Hormones and hormonal mechanisms
|
|
Yes
|
| N2 Transduced TIL |
Biologic therapy (BRM, immunotherapy)
|
|
Yes
|
| Psoralen |
Ancillary Agent
|
|
Yes
|
| MX6 |
Chemotherapy
|
Cervical cancer
|
Yes
|
| Uridine |
Chemotherapy
|
|
Yes
|
| Ethyl-6-Mercaptopurine |
Chemotherapy
|
|
Yes
|
| Methylmercaptopurine riboside |
Chemotherapy
|
|
Yes
|
| Ponatinib |
Chemotherapy
|
CML,
Chronic myeloid leukemia,
Ph+ALL,
Philadelphia-chromosome positive acute lymphoblastic leukemia,
Acute lymphoblastic leukemia,
ALL
|
Yes
|
| Ethoglucid |
Chemotherapy
|
|
Yes
|
| Mitocromin |
Chemotherapy
|
|
Yes
|
| ERA 923 |
Hormones and hormonal mechanisms
|
Breast cancer
|
Yes
|
| Myeloma-derived Idiotypic Antigen Vaccine |
Biologic therapy (BRM, immunotherapy)
|
Multiple myeloma
|
Yes
|
| Gilotrif |
Chemotherapy
|
Lung (NSCLC)
|
Yes
|
| NovoTTF-100A system |
Other therapy
|
Brain (Recurrent Glioblastoma Multiforme) GBM
|
Yes
|
| Methandrostenolone |
Hormones and hormonal mechanisms
|
|
Yes
|
| Triethylenemelamine |
Chemotherapy
|
|
Yes
|
| Equilin |
Hormones and hormonal mechanisms
|
|
Yes
|
| Tanespimycin |
Chemotherapy
|
advanced solid tumors,
CLL,
NHL,
prolymphocytic leukemia
|
Yes
|
| Flutamide |
Hormones and hormonal mechanisms
|
Prostate cancer
|
Yes
|
| Flurocitabine |
Chemotherapy
|
|
Yes
|
| Flurandrenolide |
Hormones and hormonal mechanisms
|
|
Yes
|
| Fluoroadenosine |
Chemotherapy
|
|
Yes
|
| Etanidazole |
Ancillary Agent
|
|
Yes
|
| Triapine |
Chemotherapy
|
biliary,
Breast,
colorectal,
gallbladder,
head & neck,
leukemia,
lung,
prostate,
skin cancer
|
Yes
|
| Mitoguazone |
Chemotherapy
|
AIDS,
Opportunistic infection
|
Yes
|
| 1018-ISS |
Chemotherapy
|
Lymphoma
|
Yes
|
Home
